Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: Case report and review of the literature Academic Article uri icon

Overview

MeSH Major

  • Amino Acids
  • Antifungal Agents
  • Candida albicans
  • Echinocandins
  • Lipopeptides
  • Nucleic Acids

abstract

  • Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

publication date

  • March 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5419068

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofx040

PubMed ID

  • 28491888

Additional Document Info

start page

  • ofx040

volume

  • 4

number

  • 2